Signature Care Nicotine Lozenge
Product Images NDC 21130-700

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Signature Care Nicotine (NDC 21130-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safeway, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine-lozenge-image 1 (344 Lj Nicotine Lozenge Image 1)

Nicotine-lozenge-image 1 (344 Lj Nicotine Lozenge Image 1)
This is a product description for a nicotine lozenge that is meant to aid in quitting smoking. The lozenge contains 2mg of nicotine polacrilex and comes in a mint flavor. It is intended for those who smoke their first cigarette more than 30 minutes after waking up. The packaging includes 12 lozenges and 3 quit tube containers with 24 lozenges each. The product has a tamper-evident feature in the form of dots and is comparable to Nicorette® Lozenge.*
FDA Label Image

Nicotine-lozenge-image 2 (344 Lj Nicotine Lozenge Image 2)

FDA Label Image

Wallet_card (Image 01)

Wallet_card (Image 01)
The text provides information on a wallet-sized card that likely serves as a reminder or emergency contact card. It lists phone numbers for different organizations that can offer help in case of medical emergencies related to lung diseases, cancer, and heart conditions. It also suggests seeking support from a quitting buddy or friend who has successfully quit unhealthy habits.*
FDA Label Image

Wallet‑_card (Image 02)

FDA Label Image

Smoke_free_logo (Image 03)

FDA Label Image

Upc_example (Image 04)

FDA Label Image

Stickers (Image 05)

Stickers (Image 05)
The text describes reminders to be placed on a calendar for a quitting smoking program, including the frequency of using a lozenge every 1-2 hours or 2-4 hours, based on the stage of the program. Additionally, it mentions a reminder for 12 weeks after the quit date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.